Orforglipron Led to Significantly Greater Reductions in Weight Than Placebo
Posted4 months agoActive4 months ago
nejm.orgResearchstory
skepticalmixed
Debate
20/100
Obesity TreatmentGlp-1 DrugsClinical Trials
Key topics
Obesity Treatment
Glp-1 Drugs
Clinical Trials
A new study published in the NEJM found that Orforglipron resulted in significant weight loss compared to placebo, but the HN community is skeptical about its relative effectiveness compared to other GLP-1 drugs.
Snapshot generated from the HN discussion
Discussion Activity
Light discussionFirst comment
2h
Peak period
1
1-2h
Avg / period
1
Key moments
- 01Story posted
Sep 16, 2025 at 8:44 PM EDT
4 months ago
Step 01 - 02First comment
Sep 16, 2025 at 10:20 PM EDT
2h after posting
Step 02 - 03Peak activity
1 comments in 1-2h
Hottest window of the conversation
Step 03 - 04Latest activity
Sep 16, 2025 at 10:20 PM EDT
4 months ago
Step 04
Generating AI Summary...
Analyzing up to 500 comments to identify key contributors and discussion patterns
Discussion (1 comments)
Showing 1 comments
wmf
4 months ago
It's better than placebo but it's only the 4th best GLP-1 drug.
View full discussion on Hacker News
ID: 45270173Type: storyLast synced: 11/17/2025, 2:08:38 PM
Want the full context?
Jump to the original sources
Read the primary article or dive into the live Hacker News thread when you're ready.